期刊文献+

β-环糊精对阿克他利的包合作用

Inclusion Effect of Actarit with β-Cyclodextrin
下载PDF
导出
摘要 考察了β-环糊精(β-CD)对阿克他利(Actarit,简称Acta)的包合作用.应用旋光度法确定包合比例为1∶1;相溶解度法表明,随着β-CD浓度的增大,阿克他利的溶解度随之增加;比较包合物的不同制备方法发现,饱和水溶液法收率和载药量最高,并用饱和水溶液法制备了Acta-β-CD包合物,同时,采用红外光谱和差示扫描量热法对其性质进行了表征. The inclusion effect of actarit with β-cyclodextrin was studied.The inclusion ratio of actarit to β-cyclodextrin was 1 : 1 according to the optical activity. The result from phase solubility method indicated that the apparent solubility of actarit is enhanced with the increase of β-cyclodextrin concentration.Different preparation methods are compared and it is found that the output and drug loading percent from the method of saturated aqueous solution are the highest.The inclusion complex is prepared by saturated aqueous solution method and characterized with infrared spectra ( FTIR ) and differential scanning calorimeter ( DSC ) .
出处 《天津科技大学学报》 CAS 2008年第1期21-24,共4页 Journal of Tianjin University of Science & Technology
基金 天津科技大学自然科学基金资助项目(20050205)
关键词 阿克他利 Β-环糊精 包合物 旋光度法 相溶解度法 actarit β-cyclodextrin inclusion complex optical activity method phase solubility method
  • 相关文献

参考文献9

  • 1[1]Sakurai T,Iso T,Inoue H,et al.Effect of actarit combin-ation therapy in patients with active rheumatoid arthritis resistant to gold agents[J].Ryumachi,2001,41(3):635-645.
  • 2贺俊峰,恽榴红.化学合成免疫调节剂研究进展[J].中国新药杂志,2005,14(5):547-550. 被引量:4
  • 3[3]Nakamura H,Ueki Y,Sakito S,et al.Clinical effects of actarit in rheumatoid arthritis:improvement of early disease activity mediated by reduction of serum concentrations of nitric oxide[J].Clin Exp Rheumatol,2000,18(4):445-450.
  • 4朱琦,周嘉陵,何东仪.阿克他利治疗68例类风湿关节炎病人的随机双盲对照试验[J].中国新药与临床杂志,2004,23(5):276-278. 被引量:5
  • 5[5]Susana S,Paulo R,Martyn P,et al.Interactions of omeprazole and precursors with β-cyclodextrin host molecules[J].Inclusion Phenomena and Macrocyclic Chemistry,2003,47:47-52.
  • 6[7]Paola M,Faucci M T,Gian P B.The influences of polyvinylpyrrolidone on naproxen complexation with hydroxypropyl-β-cyclodextrin[J].Eur J Pharm.Sci,2001,13(2):187-190.
  • 7赵立平,曹德英,冯香萍,袁丽华.盐酸西替利嗪-β-环糊精包合物的研制[J].华西药学杂志,2004,19(1):30-32. 被引量:13
  • 8[9]Higuchi T,Connors K A.Phase solubility techniques[J].Adv Anal Instr,1965,4:117.
  • 9童岩,姬小明,郑纯宁,张广明.美多心安-β-环糊精包合物的鉴定[J].河南科学,2005,23(3):359-361. 被引量:6

二级参考文献35

  • 1奚念朱.药剂学[M].北京:人民卫生出版社,1997.362-363.
  • 2千寿制药株式会社.眼用或鼻用抗过敏组合物[P].发明专利说明书.CN1050514c.1999-12-10.
  • 3金涌 李俊 张运芳等.阿克他利对佐剂性关节炎大鼠的治疗作用及部分机制研究[J].中国药理学通报,2000,16(6):678-81.
  • 4Hedlund G, Link H, Zhu J, et al. Effects of Linomide on immune cells and cytokines inhibit autoimmune pathologies of the central and peripheral nervous system [ J ]. Int Immunopharmacol,2001,1(6):1123- 1130.
  • 5Gross DJ, Weiss L, Reibstein I, et al The immunomodulator Linomide:role in treatment and prevention of autoimmune diabetes mellitus [ J ]. Int Immunopharmacol, 2001,1 (6) : 1131 -1139.
  • 6Shi J, Xiao ZL,Michael I, et al. Structure-activity relationships studies of the anti-angiogenic activities of linomide [ J ]. Bioorg Med Chem Lett,2003,13(6):1187- 1189.
  • 7Weiss L, Barak V, Zeira M, et al. Cytokine production in Linomide-treated nod mice and the potential role of a Th(1)/Th(2) shift on autoimmune and anti-inflammatory processes [J]. Cytokine ,2002,19(2) : 85 - 93.
  • 8Dimitrios K, Oded A, Yuta R, et al, Linomide downregrulates autoimmunity through induction of th2 cytokine production by lymphocytes[ J ]. Immunol Lett, 1999,67(3) : 203 - 208.
  • 9Noseworthy JH, Wolinsky JS, Lublin FD, et al. Linomide in relapsing and secondary progressive MS: part I: trial design and clinical results[ J ]. Neurology, 2000,54 ( 9 ) : 1726 - 1733.
  • 10Tsuji K, Spears GW, Nakamura K. Synthesis and antinephritic activities of quinoline - 3-carboxamides and related compounds [J].Bioorg Med Chem Lett, 2002,12( 1 ) : 85 - 88.

共引文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部